The Harvard-led, peer-reviewed study of about 325 mother–daughter pairs found that higher maternal PFAS levels during pregnancy were associated with a 2.3–2.7× greater likelihood that daughters would develop PMOS (formerly PCOS) or moderate-to-severe acne by adolescence. Researchers highlighted N-EtFOSAA and PFNA as compounds of concern and noted that N-EtFOSAA can degrade into the toxic PFOS. The study’s modest sample size and demographic skew mean further research is needed to confirm causation and broaden applicability.
Harvard-Led Study Finds Prenatal PFAS Exposure Linked To Higher PMOS Risk In Daughters
PMOS is estimated to impact about 13% of women.Photograph: megaflopp/Getty Images/iStockphoto(Photograph: megaflopp/Getty Images/iStockphoto)
New peer-reviewed research led by Harvard University reports the first evidence linking prenatal exposure to PFAS — the persistent “forever chemicals” — with a higher risk that daughters will develop polyendocrine metabolic ovarian syndrome (PMOS) and moderate-to-severe acne by adolescence.
Key Findings
The study followed roughly 325 mother–daughter pairs from the Boston-area Project Viva cohort and measured PFAS concentrations in maternal blood during pregnancy. Daughters whose mothers had higher prenatal PFAS levels were 2.3 to 2.7 times more likely to develop PMOS or moderate-to-severe acne in their teenage years.
“This is another piece that fits in that larger body of evidence of these specific harms, like hormonal disruption,” said Tasha Stoiber, a senior scientist at the Environmental Working Group, who reviewed the paper but was not an author.
Which Chemicals Were Implicated?
Researchers identified a correlation between PMOS and elevated levels of N-EtFOSAA, a PFAS precursor commonly found in stain guards, certain pesticides, textile water repellents and some paper coatings. N-EtFOSAA can degrade into PFOS in the environment, and PFOS is considered among the more toxic PFAS. Another compound, PFNA, was associated with higher odds of moderate-to-severe acne.
What Is PMOS?
PMOS is the updated name for what was previously called polycystic ovarian syndrome (PCOS). The rename — adopted in May to emphasize systemic endocrine and metabolic dysfunction rather than an ovary-only problem — reflects a broader understanding of how the condition affects hormonal signaling across the body. PMOS symptoms include irregular periods, excess hair growth, acne and fertility challenges; it is estimated to affect roughly 13% of women, though many cases are undiagnosed.
Study Strengths And Limitations
The long follow-up and measurement of prenatal PFAS exposure strengthen the study’s contribution to understanding potential developmental origins of PMOS. However, authors and reviewers note important limitations: the sample size is modest (~325 pairs), and the cohort is disproportionately white and college-educated, which may limit generalizability. The findings show association, not definitive causation, and the authors call for further research to confirm mechanisms and replicate results in larger, more diverse populations.
Practical Takeaways
PFAS are widely used to make products water-, stain- and grease-resistant and are difficult to avoid. Experts suggest practical steps to reduce exposure, especially for people who are pregnant or planning pregnancy: avoid stain guards and PFAS-treated waterproof textiles, ask manufacturers about PFAS-free treatments, reduce consumption of ultra-processed foods and packaging likely to contain PFAS residues, and favor whole, minimally processed foods prepared at home.
While more research is needed, this study adds to a growing body of evidence that prenatal chemical exposures can have lasting effects on endocrine and metabolic health.
Help us improve.
